Accuride Corp. (ACW) Hits New 52-week Low During January 20 Session

Equities Staff |

Accuride Corp. (ACW) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.83, Accuride Corp. dropped to $0.74 for a new 52-week low. By the closing bell, the company's stock was at $0.83 a share for a loss of 0.44%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

Accuride Corp. saw 352,652 shares of its stock trade hands, that's out of 47.95 million shares outstand. The stock has an average daily volume of 254,990 shares. After hitting a new 52-week low, Accuride Corp. enters the new trading day with a market cap of 39.81 million, a 50-day SMA of $2.00 and a 200-day SMA of $3.29

Accuride Corp. now has a P/E ratio of 16.7.

For a complete fundamental analysis analysis of Accuride Corp., check out Equities.com’s Stock Valuation Analysis report for ACW. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

Accuride Corp is a manufacturer & supplier of commercial vehicle components in North America. Its products include commercial vehicle wheels, wheel-end components & assemblies, truck body & chassis parts, and ductile & gray iron castings.

Accuride Corp. has 2,100 employees, is led by CEO Richard F. Dauch, and makes its home in Evansville, IN.

Accuride Corp. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.